circSMAD2 inhibits the epithelial & ndash;mesenchymal transition by targeting miR-629 in hepatocellular carcinoma

Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research